Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
SSX1
REST API REST API
Homo sapiens
SSX1 is differentially expressed in 139 experiments: 56 organism parts: mammary gland, testis, ... (54 more);, 67 disease states: normal, acute myeloid leukemia, ... (65 more);, 37 cell types 206 cell lines 11 compound treatments and 58 other conditions.
Synonyms CT5.1
Orthologs Ssxb3 (Mus musculus)   Ssxb6 (Mus musculus)   Ssxb8 (Mus musculus)   Gm14459 (Mus musculus)   Ssxb1 (Mus musculus)   Gm6592 (Mus musculus)   Gm5751 (Mus musculus)   Ssxb9 (Mus musculus)   Ssxb10 (Mus musculus)   Ssx9 (Mus musculus)   Ssxb2 (Mus musculus)   SSX5 (Bos taurus)   Ssxb5 (Mus musculus)   Ssx1 (Rattus norvegicus)   D3ZMV2_RAT (Rattus norvegicus)   Ssxa1 (Mus musculus)   ENSCAFG00000015307 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term regulation of transcription, DNA-dependent, intracellular, transcription corepressor activity, nucleic acid binding, nucleus
InterPro Term Krueppel-associated_box, Krueppel-associated_box-rel, SSXRD_motif
UniProt Accession Q16384
Search EB-eye ENSG00000126752
Show more properties
Experimental Factors
Organism part

studied in E-AFMX-5, E-GEOD-17189, E-GEOD-22541, E-MTAB-24, E-MTAB-25, ... (15 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-1309, E-GEOD-14464, E-GEOD-22639, ... (24 experiments)

Factor Value U/D Experiments
MCF-7
3
 E-GEOD-20081, E-GEOD-19639, E-GEOD-5823
DU145
2
 E-GEOD-17482, E-GEOD-20089
K562
2
 E-MTAB-37, E-GEOD-24147
LNCaP
2
 E-GEOD-14990, E-GEOD-14464
H15
1
 E-GEOD-1309
MDAMB453
1
 E-MTAB-37
200 more value(s).


Cell type

studied in E-GEOD-15893, E-GEOD-18811, E-MTAB-25, E-GEOD-20033, E-GEOD-3920, ... (20 experiments)

Factor Value U/D Experiments
memory B cell
1
 E-TABM-702
iPS cells from episomal vectors (Defined Factor sub-clone)
1
 E-GEOD-20033
centroblast
1
 E-GEOD-15271
centrocyte
1
 E-GEOD-15271
neutrophil
1
 E-GEOD-12662
immortalised T lymphocytes
1
 E-GEOD-13909
31 more value(s).


Disease state

studied in E-GEOD-5390, E-GEOD-3307, E-GEOD-19743, E-GEOD-3744, E-GEOD-15960, ... (20 experiments)

Factor Value U/D Experiments
B-cell acute lymphocytic leukemia
1
1
 E-MTAB-37
DiseaseState
2
1
 E-MEXP-1243
FKRP mutation
1
 E-GEOD-3307
gastric carcinoma
1
 E-MTAB-37
Down syndrome
1
 E-GEOD-5390
chronic myeloid leukemia
1
 E-MTAB-62
61 more value(s).


Compound treatment

studied in E-MEXP-1269, E-MEXP-1335, E-GEOD-5230, E-GEOD-7307, E-MEXP-941, ... (6 experiments)

Factor Value U/D Experiments
5-aza-2'-deoxycytidine
2
2
 E-GEOD-5230, E-MEXP-1269
5-aza-2'-deoxycytidine + trichostatin A
2
 E-GEOD-5230, E-MEXP-1269
Cxcl12
1
1
 E-GEOD-7307
estradiol
4
1
 E-GEOD-20081
no estradiol
1
 E-GEOD-20081
placebo
1
 E-MEXP-1335
5 more value(s).


Age at diagnosis

studied in E-GEOD-3494

Factor Value U/D Experiments
88
1
 E-GEOD-3494
87
1
 E-GEOD-3494


Biopsy tissue
studied in E-GEOD-5851

BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-22097, E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-MEXP-2359

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643

Epiregulin elisa conc ng ml
studied in E-GEOD-5851

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-7578, E-MEXP-2340

Genotype
studied in E-TABM-1029, E-GEOD-17476, E-TABM-601

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MTAB-197, E-GEOD-974, E-MEXP-2069, E-GEOD-19330, E-TABM-666, ... (18 experiments)

Infection
studied in E-GEOD-12108, E-GEOD-9723, E-MEXP-561

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Performer
studied in E-LGCL-5

Phenotype
studied in E-GEOD-21750

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246

Replicate
studied in E-GEOD-10797, E-GEOD-10896

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-11428

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-19246, E-GEOD-13818, E-GEOD-19815

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4922

Processing time: 0.525 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM